Stage IV Cutaneous Melanoma AJCC v6 and v7

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00724	Imiquimod	0	Active Not Recruiting	1
DB09037	Pembrolizumab	0	Active Not Recruiting	1
DB00041	Aldesleukin	1	Active Not Recruiting	1
DB00041	Aldesleukin	1	Recruiting	1
DB04849	Cediranib	1	Active Not Recruiting	1
DB00531	Cyclophosphamide	1	Recruiting	1
DB08912	Dabrafenib	1	Active Not Recruiting	1
DB08912	Dabrafenib	1	Terminated	1
DB01073	Fludarabine	1	Recruiting	1
DB15127	Hydrogen	1	Active Not Recruiting	1
DB01611	Hydroxychloroquine	1	Active Not Recruiting	1
DB09053	Ibrutinib	1	Active Not Recruiting	1
DB17467	Interleukin-15, human recombinant	1	Completed	1
DB06186	Ipilimumab	1	Terminated	2
DB17107	Lifileucel	1	Recruiting	1
DB16828	MK-2206	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Terminated	2
DB06306	Onalespib	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1	Active Not Recruiting	1
DB00740	Riluzole	1	Active Not Recruiting	1
DB06176	Romidepsin	1	Active Not Recruiting	1
DB11689	Selumetinib	1	Active Not Recruiting	1
DB00398	Sorafenib	1	Active Not Recruiting	1
DB14546	Sulfate ion	1	Active Not Recruiting	1
DB08911	Trametinib	1	Active Not Recruiting	1
DB08911	Trametinib	1	Terminated	1
DB00041	Aldesleukin	1 / 2	Completed	1
DB00531	Cyclophosphamide	1 / 2	Completed	1
DB08912	Dabrafenib	1 / 2	Active Not Recruiting	1
DB01073	Fludarabine	1 / 2	Completed	1
DB05996	Glembatumumab vedotin	1 / 2	Withdrawn	1
DB06186	Ipilimumab	1 / 2	Completed	1
DB06186	Ipilimumab	1 / 2	Withdrawn	1
DB17107	Lifileucel	1 / 2	Completed	1
DB15994	Methane	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Completed	1
DB09035	Nivolumab	1 / 2	Withdrawn	1
DB09037	Pembrolizumab	1 / 2	Active Not Recruiting	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB00571	Propranolol	1 / 2	Recruiting	1
DB08911	Trametinib	1 / 2	Active Not Recruiting	1
DB11969	Uprosertib	1 / 2	Active Not Recruiting	1
DB08885	Aflibercept	2	Completed	1
DB00062	Albumin human	2	Completed	1
DB00041	Aldesleukin	2	Completed	4
DB11595	Atezolizumab	2	Terminated	1
DB11105	Benzalkonium	2	Active Not Recruiting	1
DB00112	Bevacizumab	2	Active Not Recruiting	1
DB00112	Bevacizumab	2	Completed	1
DB11967	Binimetinib	2	Active Not Recruiting	1
DB11059	Carboxymethylcellulose	2	Completed	1
DB00531	Cyclophosphamide	2	Completed	3
DB08912	Dabrafenib	2	Active Not Recruiting	2
DB12021	Dinaciclib	2	Active Not Recruiting	1
DB11718	Encorafenib	2	Active Not Recruiting	1
DB01073	Fludarabine	2	Completed	2
DB17293	Hiltonol	2	Completed	1
DB09053	Ibrutinib	2	Active Not Recruiting	2
DB05258	Interferon alfa	2	Active Not Recruiting	1
DB00105	Interferon alfa-2b	2	Active Not Recruiting	1
DB06186	Ipilimumab	2	Active Not Recruiting	3
DB06186	Ipilimumab	2	Completed	3
DB00123	Lysine	2	Completed	1
DB15994	Methane	2	Active Not Recruiting	1
DB00220	Nelfinavir	2	Terminated	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Completed	1
DB06132	Nivolumab	2	Terminated	1
DB09035	Nivolumab	2	Terminated	1
DB01229	Paclitaxel	2	Completed	1
DB06589	Pazopanib	2	Completed	1
DB09037	Pembrolizumab	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Completed	1
DB09037	Pembrolizumab	2	Terminated	1
DB15185	Rasdegafusp alfa	2	Completed	1
DB14851	Relatlimab	2	Completed	1
DB00020	Sargramostim	2	Active Not Recruiting	1
DB13896	Talimogene laherparepvec	2	Active Not Recruiting	1
DB08911	Trametinib	2	Active Not Recruiting	2
DB06186	Ipilimumab	2 / 3	Recruiting	1
DB09035	Nivolumab	2 / 3	Recruiting	1
DB00020	Sargramostim	2 / 3	Recruiting	1
DB11105	Benzalkonium	3	Active Not Recruiting	1
DB05258	Interferon alfa	3	Active Not Recruiting	1
DB00105	Interferon alfa-2b	3	Active Not Recruiting	1
DB06186	Ipilimumab	3	Active Not Recruiting	1
DB00020	Sargramostim	3	Completed	1
DB16626	Tyrosinase	3	Completed	1